Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Intra-operative assessment of sentinel lymph node status by one-step nucleic acid amplification assay (OSNA) in early endometrial cancer: a prospective study.

Monterossi G, Buca D, Dinoi G, La Fera E, Zannoni GF, Spadola S, Scambia G, Fanfani F.

Int J Gynecol Cancer. 2019 Jul;29(6):1016-1020. doi: 10.1136/ijgc-2018-000113. Epub 2019 Jun 6.

PMID:
31175137
2.

Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study.

Stacchiotti S, Morosi C, Lo Vullo S, Casale A, Palassini E, Frezza AM, Dinoi G, Messina A, Gronchi A, Cavalleri A, Venturelli E, Morelli D, Pilotti S, Collini P, Brich S, Tamborini E, Mariani L, Casali PG.

Cancer. 2018 Oct 15;124(20):4056-4063. doi: 10.1002/cncr.31685. Epub 2018 Sep 14. Erratum in: Cancer. 2019 Nov 1;125(21):3893.

3.

The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study.

Buda A, Restaino S, Di Martino G, De Ponti E, Monterossi G, Dinoi G, Magni S, Quagliozzi L, Dell'Orto F, Ciccarone F, Lamanna M, Scambia G, Landoni F, Fanfani F.

Eur J Surg Oncol. 2018 Oct;44(10):1562-1567. doi: 10.1016/j.ejso.2018.06.034. Epub 2018 Jul 24.

PMID:
30077521
4.

One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer.

Fanfani F, Monterossi G, Ghizzoni V, Rossi ED, Dinoi G, Inzani F, Fagotti A, Gueli Alletti S, Scarpellini F, Nero C, Santoro A, Scambia G, Zannoni GF.

PLoS One. 2018 Apr 26;13(4):e0195877. doi: 10.1371/journal.pone.0195877. eCollection 2018.

5.

The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers.

Buda A, Di Martino G, Restaino S, De Ponti E, Monterossi G, Giuliani D, Ercoli A, Dell'Orto F, Dinoi G, Grassi T, Scambia G, Fanfani F.

Gynecol Oncol. 2017 Dec;147(3):528-534. doi: 10.1016/j.ygyno.2017.09.033. Epub 2017 Oct 9.

PMID:
29032824
6.

The impact of combined nutraceutical supplementation on quality of life and metabolic changes during the menopausal transition: a pilot randomized trial.

Villa P, Amar ID, Bottoni C, Cipolla C, Dinoi G, Moruzzi MC, Scambia G, Lanzone A.

Arch Gynecol Obstet. 2017 Oct;296(4):791-801. doi: 10.1007/s00404-017-4491-9. Epub 2017 Aug 29.

PMID:
28852842
7.

Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe?

Monterossi G, Ghezzi F, Vizza E, Zannoni GF, Uccella S, Corrado G, Restaino S, Quagliozzi L, Casarin J, Dinoi G, Scambia G, Fanfani F.

J Minim Invasive Gynecol. 2017 Mar - Apr;24(3):438-445. doi: 10.1016/j.jmig.2016.12.022. Epub 2017 Jan 5.

PMID:
28065812
8.

Cytotoxic extravasation: an issue disappearing or a problem without solution?

Ferrari LA, Dinoi GL, Saibene G, Re B, Balzarini A, Giordano L, Sala E, Bregant C.

Tumori. 2016 Jun 2;2016(3):290-3. doi: 10.5301/tj.5000486. Epub 2016 Mar 22.

PMID:
27032703
9.

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection.

Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A.

Aliment Pharmacol Ther. 2015 May;41(9):835-43. doi: 10.1111/apt.13144. Epub 2015 Mar 1.

Supplemental Content

Support Center